The Science And Economics Of Electroceuticals

Electronics and Electrical · June 6, 2017

2 min read · 0 comments

Throughout history, man has looked towards the future to find ways to improve ways of treating acute and chronic health conditions. Over the last half a century, the focus has been on moving from managing conditions with medications to being able to treat conditions with the use of implants and devices that take over the functioning of the body or assist the body in functioning.

What Are Bioelectronics?

Electroceuticals are an advancement on medical implants. They are sometimes also called bioelectronics, and they are an alternative to medications for the treatment of specific types of conditions. These are extremely small devices that are implanted in the body the body and generate electrical impulses that stimulate different parts of the body.

The most common use of electroceuticals is in pain management and the treatment of neurological and central nerve system disorders and conditions. In these applications, the implants are able to respond to read the signals produced by the body, targeting the treatment area and stimulating the corresponding system in the body.

The Benefits

For pharmaceutical companies, the move into electroceuticals offers a way to provide effective treatment without the risk of side-effects and possible costly litigation. In addition, these products offer a long life cycle when compared to other treatment options, providing greater support for patients.

The economics of the move into bioelectronics has not been lost on the pharmaceutical companies. In the last few years, the National Institute of Health provided over $250million in research in this area. One of the larger drug companies, GlaxoSmithKline, established a $50 million venture capital fund in 2013 with multiple other companies coming forward with new products and research incentives.

DARPA or the Defense Advanced Research Projects Agency in the USA has also committed to seven different electronic prescriptions (ElectRx) projects with the first project funded with a $78.9 million budget. This project includes the study of nano-sized devices for nerve modulation after trauma or illness.

At NEO Tech, we are working with leaders in the field of electroceuticals in the production of new and innovative treatment options. To find out more see us

Share this entry
AB

About the writer

Amelia Boyd

Amelia Boyd's writing prowess knows no bounds, as she ardently crafts illuminating articles and captivating blogs spanning a diverse array of subjects. Armed with a meticulous attention to detail and a penchant for exhaustive research, she plunges into the depths of each topic, furnishing readers with content that is both precise and captivating.

Embarking on her writing odyssey years ago, driven by an insatiable curiosity and a passion for disseminating knowledge, Amelia's unwavering commitment to excellence has garnered accolades from audiences and peers alike. Whether dissecting intricate scientific principles, dissecting the latest technological trends, or unraveling the nuances of art and culture, she approaches each subject matter with boundless enthusiasm and expertise.

Holding a foundation in journalism and a steadfast dedication to staying abreast of current events, Amelia ensures that her writing remains not only informative but also pertinent and timely. Her adeptness at distilling complex ideas into digestible prose renders her articles and blogs invaluable resources for those in search of lucidity and enlightenment.

Away from her writing desk, Amelia can be found exploring the great outdoors, indulging her passion for photography, or immersing herself in the pages of a captivating book.

View all 8,456 articles →